{"organizations": [], "uuid": "63f60684b1538c0c9550a71a0bf35c327b2e42af", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180409.html", "section_title": "Archive News &amp; Video for Monday, 09 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-mereo-biopharma-says-offering-159/brief-mereo-biopharma-says-offering-15-9-mln-of-ordinary-shares-including-ordinary-shares-in-form-of-adss-in-global-offering-idUSFWN1RM07Z", "country": "US", "domain_rank": 408, "title": "BRIEF-Mereo Biopharma Says Offering 15.9 Mln Of Ordinary Shares, Including Ordinary Shares In Form Of ADSS, In Global Offering", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-04-09T18:34:00.000+03:00", "replies_count": 0, "uuid": "63f60684b1538c0c9550a71a0bf35c327b2e42af"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-mereo-biopharma-says-offering-159/brief-mereo-biopharma-says-offering-15-9-mln-of-ordinary-shares-including-ordinary-shares-in-form-of-adss-in-global-offering-idUSFWN1RM07Z", "ord_in_thread": 0, "title": "BRIEF-Mereo Biopharma Says Offering 15.9 Mln Of Ordinary Shares, Including Ordinary Shares In Form Of ADSS, In Global Offering", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "mereo biopharma group plc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "united states", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 9 (Reuters) - Mereo BioPharma Group PLC:\n* SAYS OFFERING 15.9 MLN OF COâ€™S ORDINARY SHARES, INCLUDING ORDINARY SHARES IN FORM OF ADSS, IN GLOBAL OFFERING SEC FILING - SEC FILING\n* MEREO BIOPHARMA GROUP PLC SAYS OFFERING 2.8 MILLION ADSS THROUGH UNDERWRITERS IN THE UNITED STATES, OR THE U.S. OFFERING Source text ( bit.ly/2H82gCU ) Further company coverage:\n ", "external_links": ["https://bit.ly/2H82gCU", "https://www.youtube.com/user/ReutersVideo", "https://twitter.com/reuters", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-09T18:34:00.000+03:00", "crawled": "2018-04-10T12:48:51.000+03:00", "highlightTitle": ""}